(Haim) 13-Year-Old-Cat with Stage 3 CKD Enjoys Better Energy Until the End with AIM Care

Haim, a 13-year-old spayed female cat, was diagnosed with CKD in October 2022. One of her kidneys was completely damaged, while the other was in late-stage CKD.  In March 2024, she began AIM-based care to help slow disease progression and improve her well-being.


Haim had late stage 2 CKD, but recovered her vitality with AIM care.
  • Age: 13 years
  • Sex: Spayed Female
  • Weight: 6.8 kg
  • Condition: Stage 3 CKD, P. aeruginosa infection
  • Symptoms & Concerns: High creatinine and BUN levels, deteriorating kidney function, elevated liver levels
  • Previous Treatments: Renal supplements, digestive support, liver support, omega-3, antibiotics, controlled water intake, and stem cell therapy (periodic)
  • Supplements Introduced: Dr. Toru Protocol

Haim’s Health Improvements

Haim began AIM supplementation in March and showed significant improvements in kidney function by April.

Health Metric Before After Change
Creatinine (CREA) 4.6 2.9 Decreased (better kidney waste filtration)
BUN Levels 99 73 Decreased (reduced nitrogen waste buildup)
Phosphorus Levels 5.4 6.3 Slight Increase (monitor phosphorus management)

 

Haim's blood test results show decreased creatinine and BUN levels with AIM care.

How Did Haim Improve?

Energy & Activity

  • Showed increased energy levels after AIM supplementation.
  • Became more responsive and engaged in daily activities.
  • Displayed improved movement and willingness to interact.

Weight & Appetite

  • Appetite remained stable throughout the supplementation period.

Appearance & Other Changes

  • Used to lack hind leg strength to the point where she couldn't stand, walk, sit, or even use the litter box properly, but could move around with ease after AIM supplementation.

Supplement Adjustments

  • Dr. Toru Protocol was introduced in March at a carefully managed dosage.

Haim's creatinine and BUN levels decreased significantly within 1 month of AIM supplementation, stabilizing her kidney condition. Given her history of severe kidney damage, these improvements were remarkable. Her owner noted that despite the challenges of CKD, Haim maintained better energy levels and a stable appetite throughout the supplementation period.

In the months following her AIM care, Haim sadly passed away due to pulmonary issues unrelated to her CKD. Her owner expressed deep gratitude for the additional time spent with Haim in better spirits, as she remained energetic and engaged until her final days. Greycoat Research honors Haim’s memory and remains committed to helping cats like her maintain the best possible quality of life.

 

"Haim had been battling CKD for years, and I feared I was running out of options. When I started AIM care, I wasn’t sure what to expect, but within a month, her creatinine and BUN levels dropped! She became more energetic and engaged, which gave me hope and reassurance that I was giving her the best care possible. Watching her regain her spirit and activity brought immense relief.

Even though she is no longer with me, I will always be grateful for the extra time AIM care gave us. I hope her story can help other cats facing similar struggles, so more owners know there is hope. I truly believe that Dr. Toru Protocol played a role in managing her CKD, and I plan to use it to support another cat in my care with similar symptoms. Thank you to Greycoat Research for their guidance and help."

The protocol—now available for your cat.